BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36786170)

  • 21. Suppressors of cytokine signaling abrogate diabetic nephropathy.
    Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
    Li M; Zheng R; Yuan FL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5987-5993. PubMed ID: 30280781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
    Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
    Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of Novel Cavin-1/Suppressor of Cytokine Signaling 3 (SOCS3) Interactions by Coimmunoprecipitation, Peptide Pull-Down, and Peptide Array Overlay Approaches.
    Williams JJL; Baillie GS; Palmer TM
    Methods Mol Biol; 2020; 2169():105-118. PubMed ID: 32548823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes.
    Singh A; Jayaraman A; Hahn J
    Biotechnol Bioeng; 2006 Dec; 95(5):850-62. PubMed ID: 16752369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions.
    Khera R; Mehan S; Kumar S; Sethi P; Bhalla S; Prajapati A
    Mol Neurobiol; 2022 Jun; 59(6):3888-3912. PubMed ID: 35437700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging roles of suppressor of cytokine signaling 3 in human cancers.
    Dai L; Li Z; Tao Y; Liang W; Hu W; Zhou S; Fu X; Wang X
    Biomed Pharmacother; 2021 Dec; 144():112262. PubMed ID: 34607102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.
    Roncero AM; López-Nieva P; Cobos-Fernández MA; Villa-Morales M; González-Sánchez L; López-Lorenzo JL; Llamas P; Ayuso C; Rodríguez-Pinilla SM; Arriba MC; Piris MA; Fernández-Navarro P; Fernández AF; Fraga MF; Santos J; Fernández-Piqueras J
    Leukemia; 2016 Jan; 30(1):94-103. PubMed ID: 26216197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KLF13 Regulates the Activity of the GH-Induced JAK/STAT Signaling by Targeting Genes Involved in the Pathway.
    Ávila-Mendoza J; Delgado-Rueda K; Urban-Sosa VA; Carranza M; Luna M; Martínez-Moreno CG; Arámburo C
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylation.
    Drobna-Śledzińska M; Maćkowska-Maślak N; Jaksik R; Kosmalska M; Szarzyńska B; Lejman M; Sędek Ł; Szczepański T; Taghon T; Van Vlierberghe P; Witt M; Dawidowska M
    Genes Chromosomes Cancer; 2022 Dec; 61(12):720-733. PubMed ID: 35778917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation.
    Yan D; Li G; Yuan Y; Li H; Cao H; Dai Y; Li Y; Zhang Z; Li F; Fang Y; Gao Q
    Cancer Gene Ther; 2024 Mar; 31(3):397-409. PubMed ID: 38102464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
    Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
    Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jak/Stat signaling stimulates zebrafish optic nerve regeneration and overcomes the inhibitory actions of Socs3 and Sfpq.
    Elsaeidi F; Bemben MA; Zhao XF; Goldman D
    J Neurosci; 2014 Feb; 34(7):2632-44. PubMed ID: 24523552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling.
    Billing U; Jetka T; Nortmann L; Wundrack N; Komorowski M; Waldherr S; Schaper F; Dittrich A
    Commun Biol; 2019; 2():27. PubMed ID: 30675525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
    Durham GA; Williams JJL; Nasim MT; Palmer TM
    Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.
    Handle F; Erb HH; Luef B; Hoefer J; Dietrich D; Parson W; Kristiansen G; Santer FR; Culig Z
    Mol Cancer Res; 2016 Jun; 14(6):574-85. PubMed ID: 27053681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.